ANXA9 and ovarian serous tumor: ANXA7 mRNA downregulation was significantly correlated with poor PFS in patients with ovarian serous tumors, and ANXA9 mRNA upregulation was significantly correlated with poor OS and PFS in patients with ovarian serous tumors.